AstraZeneca and GSK fall after Trump's tariff threat
** Shares of British drug makers AstraZeneca AZN.L and GSK GSK.L fall after U.S. President Donald Trump's tariff warning on pharma sector
** AZN down 1.5% at 10,500p and GSK GSK.L falls 1.3% at 1,461.5p; both among top losers on FTSE 100 index .FTSE which is up 0.15%
** Trump on Tuesday said tariffs to the pharma sector are "coming very soon"
** Michael Field, chief equity strategist at Morningstar, says that with Trump warning of tariffs on pharma, investors are reacting negatively
** "It's already been questioned heavily whether tariffs are constitutional or not and would they go through, but in the meantime, market has taken a prudent approach and dropping valuations of pharmacy stocks"
** Including session's losses, AZN and GSK are up 0.5% and 8.6%, respectively, so far this year
Related Articles
June FOMC meeting: Fed Holds Steady Amid Crosscurrents, Why Inaction May Be the Best Policy for Now
TradingKey - On June 18, the Federal Reserve released the June FOMC statement as scheduled, maintaining the benchmark interest rate at 4.25%–4.50%, in line with market expectations. After Powell's speech, the market quickly digested. The latest dot plot shows that the probability of the Federal...
What To Invest In During a Trade War: Gold, Stocks or Bonds?
In 2025, uncertainty wears a familiar name: Trump. From volatile tariffs to abrupt policy shifts, his trade agenda has turned predictability into a luxury. But what if market chaos isn’t a threat—but a gateway to profit?
BOJ June Meeting Preview: 2025 Rate Hikes Off the Table; Slowdown in Bond Purchase Cuts?
TradingKey - On Tuesday, June 17, 2025, the Bank of Japan (BOJ) will hold its monetary policy meeting. The market widely expects that the policy interest rate will remain unchanged at 0.5%. The key focus ahead of the meeting is likely to be how quickly the BOJ will reduce its pace of scaling back...
[IN-DEPTH ANALYSIS] LULU: Can it Recover from the Drop?
TradingKey - Thesis Among the stocks of the twenty largest clothing companies by revenue, Lululemon has the fifth lowest forward PE ratio. With all the negative sentiment revolving around the stock, we believe their multiple should be higher.
